{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:06:05Z","timestamp":1789074365364,"version":"build-2803163510"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["project code 25OM +017"],"award-info":[{"award-number":["project code 25OM +017"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179269","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:12:47Z","timestamp":1787181167000},"page":"179269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mitochondrial dysfunction in ifosfamide-induced nephrotoxicity: Mechanisms and possible interventions"],"prefix":"10.1016","volume":"1033","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0965-4436","authenticated-orcid":false,"given":"Kate","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8761-9233","authenticated-orcid":false,"given":"Jolita","family":"Ciapaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1074","authenticated-orcid":false,"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-6428","authenticated-orcid":false,"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-879X","authenticated-orcid":false,"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-0134","authenticated-orcid":false,"given":"Gisela G.","family":"Slaats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6396-6585","authenticated-orcid":false,"given":"Gerrit","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179269_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4067\/S0717-95022025000200422","article-title":"Luteolin abates ifosfamide-induced nephrotoxicity by downregulating renal oxidative DNA damage, inflammation, and apoptosis in experimental rats","volume":"43","author":"Abubakr","year":"2025","journal-title":"Int. J. Morphol."},{"key":"10.1016\/j.ejphar.2026.179269_bib2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0090-9556(25)08471-5","article-title":"Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue","volume":"24","author":"Aeschlimann","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2026.179269_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00467-004-1807-3","article-title":"Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity","volume":"20","author":"Aleksa","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/a-1967-2066","article-title":"Mitochondrial transplantation therapy against ifosfamide induced toxicity on rat renal proximal tubular cells","volume":"73","author":"Arjmand","year":"2023","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.ejphar.2026.179269_bib5","first-page":"355","article-title":"Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity","volume":"10","author":"Badary","year":"1998","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000020620","article-title":"L-Histidinol attenuates Fanconi syndrome induced by ifosfamide in rats","volume":"7","author":"Badary","year":"1999","journal-title":"Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-8741(98)00242-6","article-title":"Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice","volume":"67","author":"Badary","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib8","article-title":"An AOP-guided in vitro platform for mechanistic screening of platinum-based nephrotoxicity","volume":"2","author":"Barnes","year":"2026","journal-title":"NAMTA J."},{"key":"10.1016\/j.ejphar.2026.179269_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2026.154477","article-title":"Comparative transcriptomics reveals shared stress and repair-associated pathway modules in proximal tubule cells exposed to platinum chemotherapeutics","volume":"525","author":"Barnes","year":"2026","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2026.179269_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000096177","article-title":"Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy","volume":"29","author":"Benesic","year":"2006","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1159\/000358680","article-title":"The nephrotoxic Ifosfamide-metabolite chloroacetaldehyde interferes with renal extracellular matrix homeostasis","volume":"33","author":"Benesic","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2026.179269_bib10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1523-1755.2005.00657.x","article-title":"Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity","volume":"68","author":"Benesic","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.179269_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0142(19950801)76:3<497::AID-CNCR2820760321>3.0.CO;2-C","article-title":"Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients","volume":"76","author":"Berns","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2026.179269_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/01913123.2025.2494621","article-title":"Morphometric study of proximal tubular cell mitochondria using TEM images in renal diseases","volume":"49","author":"Boruah","year":"2025","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.ejphar.2026.179269_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.exger.2010.01.003","article-title":"The sites and topology of mitochondrial superoxide production","volume":"45","author":"Brand","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejphar.2026.179269_bib17","first-page":"2676","article-title":"Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide","volume":"57","author":"Bruggemann","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/dmd.115.063628","article-title":"Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms","volume":"43","author":"Calinski","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2026.179269_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1623500","article-title":"Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges","volume":"16","author":"Cao","year":"2025","journal-title":"Front. Physiol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2026.179269_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000073369","article-title":"Ifosfamide in pediatric solid tumors","volume":"65","author":"Carli","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2026.179269_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/oxfordjournals.annonc.a058317","article-title":"The enigma of ifosfamide encephalopathy","volume":"3","author":"Cerny","year":"1992","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib22","article-title":"Cell immortality: in vitro effective techniques to achieve and investigate its applications and challenges","volume":"14","author":"Chalak","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ejphar.2026.179269_bib23","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"306","author":"Che","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2026.179269_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trsl.2007.02.001","article-title":"The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells","volume":"150","author":"Chen","year":"2007","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/bjp.2008.15","article-title":"N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats","volume":"153","author":"Chen","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2026.154440","article-title":"Mitochondrial toxicity of emerging disinfection byproduct 2,6-dichloro-1,4- benzoquinone in renal proximal tubule cells: oxidative phosphorylation impairment and metabolic reprogramming","volume":"523","author":"Chen","year":"2026","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2026.179269_bib27","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/cncr.22669","article-title":"Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma","volume":"109","author":"Chugh","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2026.179269_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/mp100329u","article-title":"New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2","volume":"8","author":"Ciarimboli","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2026.179269_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10520295.2021.2021449","article-title":"Morin mitigates ifosfamide induced nephrotoxicity by regulation of NF-kappaB\/p53 and Bcl-2 expression","volume":"97","author":"Comakli","year":"2022","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.ejphar.2026.179269_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease","volume":"100","author":"Corona","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179269_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2026.2667561","article-title":"A review of the sirtuins family: pivotal regulators and emerging therapeutic targets in renal fibrosis","volume":"48","author":"Deng","year":"2026","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejphar.2026.179269_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2021.06.050","article-title":"Late-onset kidney failure in survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"155","author":"Dieffenbach","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179269_bib34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179269_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000499245","article-title":"The effect of acetylcysteine on renal function in experimental models of cyclophosphamide-and ifosfamide-induced cystitis","volume":"14","author":"Dobrek","year":"2020","journal-title":"Curr. Urol."},{"key":"10.1016\/j.ejphar.2026.179269_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","article-title":"The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development","volume":"32","author":"Doke","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179269_bib37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.V1281615","article-title":"Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide","volume":"12","author":"Dubourg","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-18-2747","article-title":"An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines","volume":"79","author":"Dutil","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","article-title":"The significance of mitochondrial toxicity testing in drug development","volume":"12","author":"Dykens","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2026.179269_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0748233712469649","article-title":"Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity","volume":"31","author":"El-Sisi Ael","year":"2015","journal-title":"Toxicol. Ind. Health"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2026.179269_bib41","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.nephro.2018.02.008","article-title":"[Ifosphamide nephrotoxicity]","volume":"14","author":"Ensergueix","year":"2018","journal-title":"N\u00e9phrol. Th\u00e9rapeutique"},{"key":"10.1016\/j.ejphar.2026.179269_bib42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ckj\/sfz183","article-title":"Ifosfamide nephrotoxicity in adult patients","volume":"13","author":"Ensergueix","year":"2020","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ejphar.2026.179269_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nephro.2005.12.002","article-title":"[Proteinuria]","volume":"2","author":"Fauvel","year":"2006","journal-title":"N\u00e9phrol. Th\u00e9rapeutique"},{"key":"10.1016\/j.ejphar.2026.179269_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12887-024-04633-1","article-title":"Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach","volume":"24","author":"Febvey-Combes","year":"2024","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.ejphar.2026.179269_bib45","doi-asserted-by":"crossref","first-page":"146S","DOI":"10.1002\/j.1875-9114.1997.tb03817.x","article-title":"An overview of cyclophosphamide and ifosfamide pharmacology","volume":"17","author":"Fleming","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2026.179269_bib46","first-page":"1507","article-title":"Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy","volume":"3","author":"Foxall","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000013321","article-title":"End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy","volume":"18","author":"Friedlaender","year":"1998","journal-title":"Am. J. Nephrol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2026.179269_bib48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000073350","article-title":"Pharmacology of ifosfamide","volume":"65","author":"Furlanut","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2026.179269_bib49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3389\/fphys.2020.01079","article-title":"The role of mitochondria in drug-induced kidney injury","volume":"11","author":"Gai","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.179269_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000525029","article-title":"Onconephrology: update in anticancer drug-related nephrotoxicity","volume":"147","author":"Garcia-Carro","year":"2023","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2026.179269_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00280-004-0894-y","article-title":"Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide","volume":"55","author":"Germann","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00686153","article-title":"Determination of the urinary excretion of ifosfamide and its phosphorated metabolites by phosphorus-31 nuclear magnetic resonance spectroscopy","volume":"31","author":"Gilard","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/17425255.2010.487861","article-title":"Oxazaphosphorines: new therapeutic strategies for an old class of drugs","volume":"6","author":"Giraud","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib54","doi-asserted-by":"crossref","first-page":"F768","DOI":"10.1152\/ajprenal.00189.2023","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"326","author":"Guo","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2026.179269_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0091270010391790","article-title":"N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics","volume":"52","author":"Hanly","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/pat.32.3.166.170","article-title":"Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients","volume":"32","author":"Hill","year":"2000","journal-title":"Pathology"},{"key":"10.1016\/j.ejphar.2026.179269_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-physiol-042222-025000","article-title":"Mitochondrial dysfunction in kidney tubulopathies","volume":"86","author":"Hoogstraten","year":"2024","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2026.179269_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pharmrev.122.000568","article-title":"Time to change: a systems pharmacology approach to disentangle mechanisms of drug-induced mitochondrial toxicity","volume":"75","author":"Hoogstraten","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179269_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0006-2952(99)00410-4","article-title":"Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide","volume":"59","author":"Huang","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib60","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1002\/PHAR.1013","article-title":"Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide","volume":"32","author":"Ingemi","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2026.179269_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165809","article-title":"Mitochondrial transplantation ameliorates ischemia\/reperfusion-induced kidney injury in rat","volume":"1866","author":"Jabbari","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2026.179269_bib62","article-title":"The significance of ferroptosis in renal diseases and its therapeutic potential","volume":"10","author":"Jiang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2026.179269_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s002800050676","article-title":"Urinary stability of carboxycyclophosphamide and carboxyifosfamide, two major metabolites of the anticancer drugs cyclophosphamide and ifosfamide","volume":"40","author":"Joqueviel","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib64","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.freeradbiomed.2009.03.004","article-title":"Cytochrome c\/cardiolipin relations in mitochondria: a kiss of death","volume":"46","author":"Kagan","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179269_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110465","article-title":"Nephroprotective effects of hesperidin on ifosfamide-induced acute nephrotoxicity in rats: role of NF-\u03baB\/TNF-\u03b1\/IL-1\u03b2, p53\/caspase-3\/Bax\/Bcl-2, and ATF6\/IRE1\/PERK\/GRP78 signaling pathways","volume":"770","author":"Kandemir","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.179269_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdd.257","article-title":"Distribution of ifosfamide and metabolites between plasma and erythrocytes","volume":"22","author":"Kerbusch","year":"2001","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejphar.2026.179269_bib67","first-page":"4851","article-title":"Urinary neutrophil gelatinase associated lipocalin as a biomarker in ifosfamide induced chronic renal failure","volume":"19","author":"Kesik","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2026.179269_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000073351","article-title":"Side effects of ifosfamide","volume":"65","author":"Klastersky","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2026.179269_bib69","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2215\/CJN.09620911","article-title":"Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors","volume":"7","author":"Knijnenburg","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/path.6202","article-title":"Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy","volume":"261","author":"Knoppert","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179269_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tiv.2009.08.026","article-title":"Targets of chloroacetaldehyde-induced nephrotoxicity","volume":"24","author":"Knouzy","year":"2010","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2026.179269_bib72","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.12413","article-title":"Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models","volume":"171","author":"Komen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jat.3191","article-title":"Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver-kidney microfluidic data and pharmacokinetic-system biology models","volume":"36","author":"Leclerc","year":"2016","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib75","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.kint.2026.01.037","article-title":"Conventional cytotoxic chemotherapy\u2013associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup","volume":"109","author":"Lentini","year":"2026","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.179269_bib76","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2010.06.002","article-title":"Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics","volume":"80","author":"Li","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179871","article-title":"Aldehyde dehydrogenase 2 preserves kidney function by countering acrolein-induced metabolic and mitochondrial dysfunction","volume":"9","author":"Li","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2026.179269_bib77","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1369\/0022155415574818","article-title":"Cardiolipin and its different properties in mitophagy and apoptosis","volume":"63","author":"Li","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejphar.2026.179269_bib79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12859-021-04285-3","article-title":"MitoTox: a comprehensive mitochondrial toxicity database","volume":"22","author":"Lin","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2026.179269_bib80","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1542\/peds.101.6.e8","article-title":"Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors","volume":"101","author":"Loebstein","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejphar.2026.179269_bib81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/FPC.0000000000000019","article-title":"PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics","volume":"24","author":"Lowenberg","year":"2014","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.ejphar.2026.179269_bib82","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00467-005-1948-z","article-title":"Renal pathology in children with mitochondrial diseases","volume":"20","author":"Mart\u00edn-Hern\u00e1ndez","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.14573\/altex.1807041","article-title":"Animal testing and its alternatives - the most important omics is economics","volume":"35","author":"Meigs","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.ejphar.2026.179269_bib84","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0021-9258(18)62305-1","article-title":"The turnover of Mitochondria in a variety of tissues of young adult and aged rats","volume":"246","author":"Menzies","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179269_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70253","article-title":"Mitochondrial transplantation: a novel therapeutic approach for treating diseases","volume":"6","author":"Miao","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ejphar.2026.179269_bib87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00865466","article-title":"Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture","volume":"8","author":"Mohrmann","year":"1994","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib86","first-page":"289","article-title":"Inhibition of sodium-dependent transport systems in LLC-PK1 cells by metabolites of ifosfamide","volume":"15","author":"Mohrmann","year":"1992","journal-title":"Ren. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2026.179269_bib88","article-title":"Kidney organoids: current advances and applications","volume":"15","author":"Nakanoh","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ejphar.2026.179269_bib89","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050113","article-title":"A systematic review of kidney-on-a-chip-based models to study human renal (patho-)physiology","volume":"16","author":"Nguyen","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejphar.2026.179269_bib90","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.1997.140","article-title":"The kidney in mitochondrial cytopathies","volume":"51","author":"Niaudet","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.179269_bib92","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1158\/0008-5472.CAN-06-1043","article-title":"Ifosfamide-induced nephrotoxicity: mechanism and prevention","volume":"66","author":"Nissim","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib91","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ki.1996.97","article-title":"Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats","volume":"49","author":"Nissim","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.179269_bib93","series-title":"Ifosfamide","author":"Nookala","year":"2024"},{"key":"10.1016\/j.ejphar.2026.179269_bib94","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2008.17.5257","article-title":"Long-term evaluation of ifosfamide-related nephrotoxicity in children","volume":"27","author":"Oberlin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/a-1017-5085","article-title":"The nephroprotective role of carnosine against ifosfamide-induced renal injury and electrolytes imbalance is mediated via the regulation of mitochondrial function and alleviation of oxidative stress","volume":"70","author":"Ommati","year":"2020","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.ejphar.2026.179269_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejphar.2026.179269_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","article-title":"Acute kidney injury in pediatric cancer patients","volume":"208","author":"Park","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejphar.2026.179269_bib98","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1345\/aph.1G114","article-title":"Methylene blue for management of ifosfamide-induced encephalopathy","volume":"40","author":"Patel","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179269_bib99","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/bjoc.1999.0917","article-title":"Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature","volume":"82","author":"Pelgrims","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179269_bib101","series-title":"Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: a National Cohort Study","author":"Pitlo","year":"2026"},{"key":"10.1016\/j.ejphar.2026.179269_bib102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1096-911X(199609)27:3<149::AID-MPO3>3.0.CO;2-E","article-title":"Progressive glomerular toxicity of ifosfamide in children","volume":"27","author":"Prasad","year":"1996","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib103","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/s41598-025-87228-9","article-title":"GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN","volume":"15","author":"Qing","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179269_bib104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfaf169","article-title":"Nephrotoxicity and kidney outcomes in pediatric oncology patients","volume":"41","author":"Raymakers-Janssen","year":"2026","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2026.179269_bib105","doi-asserted-by":"crossref","first-page":"zqab026","DOI":"10.1093\/function\/zqab026","article-title":"Bioengineered kidney models: methods and functional assessments","volume":"2","author":"Rizki-Safitri","year":"2021","journal-title":"Function (Oxf)"},{"key":"10.1016\/j.ejphar.2026.179269_bib107","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1097\/SLA.0000000000006005","article-title":"Mitochondria transplantation mitigates damage in an In vitro model of renal tubular injury and in an Ex vivo model of DCD renal transplantation","volume":"278","author":"Rossi","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejphar.2026.179269_bib106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00865464","article-title":"Estimation of ifosfamide\/cisplatinum-induced renal toxicity by urinary protein analysis","volume":"8","author":"Rossi","year":"1994","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23570","article-title":"Evaluation of in vitro effects of ifosfamide drug on mitochondrial functions using isolated mitochondria obtained from vital organs","volume":"38","author":"Salimi","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/696704","article-title":"Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in ifosfamide-induced Fanconi syndrome rat model","volume":"2012","author":"Sayed-Ahmed","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.179269_bib110","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00424-013-1307-z","article-title":"Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter","volume":"465","author":"Schophuizen","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2026.179269_bib111","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2002.04.178","article-title":"2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American society of clinical oncology","volume":"20","author":"Schuchter","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00467-005-2006-6","article-title":"Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells","volume":"21","author":"Schwerdt","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.taap.2007.03.025","article-title":"Resveratrol improves ifosfamide-induced Fanconi syndrome in rats","volume":"222","author":"Sehirli","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-079X.2004.00131.x","article-title":"Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats","volume":"37","author":"Sener","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.toxrep.2023.04.005","article-title":"Pretreatment of ellagic acid protects ifosfamide-induced acute nephrotoxicity in rat kidneys: a mitochondrial, histopathological and oxidative stress approaches","volume":"10","author":"Shabani","year":"2023","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.ejphar.2026.179269_bib116","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00866300","article-title":"Iphosphamide-induced nephrotoxicity in children","volume":"6","author":"Shore","year":"1992","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MPH.0b013e3181f8cac0","article-title":"Nephrotoxicity--what do we know and what don't we know?","volume":"33","author":"Skinner","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00467-017-3662-z","article-title":"Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance","volume":"33","author":"Skinner","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib119","first-page":"1636","article-title":"Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study. United Kingdom Children's Cancer Study Group","volume":"82","author":"Skinner","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179269_bib120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.30.2.212","article-title":"Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels","volume":"30","author":"Slitt","year":"2002","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejphar.2026.179269_bib121","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-025-04004-0","article-title":"Pharmaceutical roots to mitochondrial routes: targeting neurodegeneration","author":"Sood","year":"2026","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib123","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11626-999-0080-y","article-title":"Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells","volume":"35","author":"Springate","year":"1999","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.ejphar.2026.179269_bib122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1099-1263(199701)17:1<75::AID-JAT397>3.0.CO;2-C","article-title":"Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo","volume":"17","author":"Springate","year":"1997","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib124","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/mnfr.201190034","article-title":"Acrolein","volume":"55","author":"Stevens","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2026.179269_bib125","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-026-03280-z","article-title":"A natural nephroprotective adjuvant for cancer chemotherapy: rosmarinic acid disrupts IL-17 A-Ferroptosis coupling in ifosfamide-induced renal injury","volume":"43","author":"S\u00fczen Celbek","year":"2026","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejphar.2026.179269_bib126","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.179269_bib127","article-title":"The atypical presentation of ifosfamide-induced renal tubular acidosis","volume":"16","author":"Vayzband","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.179269_bib128","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(24)38206-0","article-title":"Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats","volume":"289","author":"Visarius","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179269_bib129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003088-199426060-00003","article-title":"Ifosfamide clinical pharmacokinetics","volume":"26","author":"Wagner","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2026.179269_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2012.02.004","article-title":"Oxazaphosphorine bioactivation and detoxification the role of xenobiotic receptors","volume":"2","author":"Wang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179269_bib131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0024-3205(00)00915-2","article-title":"Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites","volume":"68","author":"Woodland","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179269_bib132","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/dmd.121.000742","article-title":"Species specificity and selection of models for drug oxidations mediated by polymorphic human enzymes","volume":"51","author":"Yamazaki","year":"2023","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejphar.2026.179269_bib133","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00467-007-0689-6","article-title":"In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro","volume":"23","author":"Yaseen","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2026.179269_bib134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00204-007-0275-5","article-title":"Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule","volume":"82","author":"Yaseen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179269_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120801","article-title":"Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents","volume":"306","author":"Yen","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179269_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300438","article-title":"In vivo hepatoprotective and nephroprotective effects of Stenocarpus sinuatus leaf extract against ifosfamide-induced toxicity in rats","volume":"357","author":"Younis","year":"2024","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejphar.2026.179269_bib137","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/stem.3375","article-title":"Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1\u03b1 activation","volume":"39","author":"Yuan","year":"2021","journal-title":"Stem Cell."},{"key":"10.1016\/j.ejphar.2026.179269_bib138","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0887-2333(03)00044-4","article-title":"Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells","volume":"17","author":"Zaki","year":"2003","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2026.179269_bib139","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/taap.1994.1241","article-title":"Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney","volume":"129","author":"Zamlauski-Tucker","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179269_bib140","doi-asserted-by":"crossref","DOI":"10.1063\/1.3553237","article-title":"Microfluidic devices for studying heterotypic cell-cell interactions and tissue specimen cultures under controlled microenvironments","volume":"5","author":"Zervantonakis","year":"2011","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.ejphar.2026.179269_bib142","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/03602530500364023","article-title":"Metabolism and transport of oxazaphosphorines and the clinical implications","volume":"37","author":"Zhang","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2026.179269_bib141","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","article-title":"Biomarkers of acute and chronic kidney disease","volume":"81","author":"Zhang","year":"2019","journal-title":"Annu. Rev. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600751X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600751X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:07:31Z","timestamp":1789070851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992600751X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":141,"alternative-id":["S001429992600751X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179269","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction in ifosfamide-induced nephrotoxicity: Mechanisms and possible interventions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179269"}}